[go: up one dir, main page]

CR20160055A - Composiciones tópicas para el tratamiento de sudoración excesiva y métodos para utilizar las mismas - Google Patents

Composiciones tópicas para el tratamiento de sudoración excesiva y métodos para utilizar las mismas

Info

Publication number
CR20160055A
CR20160055A CR20160055A CR20160055A CR20160055A CR 20160055 A CR20160055 A CR 20160055A CR 20160055 A CR20160055 A CR 20160055A CR 20160055 A CR20160055 A CR 20160055A CR 20160055 A CR20160055 A CR 20160055A
Authority
CR
Costa Rica
Prior art keywords
methods
same
excessive sweating
topical compositions
sweating treatment
Prior art date
Application number
CR20160055A
Other languages
English (en)
Inventor
Teodora X Pene-Dumitrescu
Elizabeth K Hussey
Maria Graziella Larm
Jon Lenn
Leon Loupenok
Michael R Luke
Leandro L Santos
Virginia D Schmith
Original Assignee
Glaxosmithkline Intellectual Property Dev Limitd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51626097&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20160055(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxosmithkline Intellectual Property Dev Limitd filed Critical Glaxosmithkline Intellectual Property Dev Limitd
Publication of CR20160055A publication Critical patent/CR20160055A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención contempla 4-­ [hidroxi(difenil)metil]-­ 1-­ {2-­[(fenilmetil)oxi]etil}-­ 1-­ azoniabiciclo[2.2.2]octano y un anión farmacéuticamente aceptable del mismo para usarse en el tratamiento tópico o profilaxis de sudoración excesiva, y composiciones que contienen estos ingredientes.
CR20160055A 2013-07-30 2016-01-29 Composiciones tópicas para el tratamiento de sudoración excesiva y métodos para utilizar las mismas CR20160055A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361859947P 2013-07-30 2013-07-30
US201461952238P 2014-03-13 2014-03-13
US201462021878P 2014-07-08 2014-07-08
PCT/IB2014/063564 WO2015015446A1 (en) 2013-07-30 2014-07-30 Topical compositions for treatment of excessive sweating and methods of use thereof

Publications (1)

Publication Number Publication Date
CR20160055A true CR20160055A (es) 2016-04-04

Family

ID=51626097

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20160055A CR20160055A (es) 2013-07-30 2016-01-29 Composiciones tópicas para el tratamiento de sudoración excesiva y métodos para utilizar las mismas

Country Status (17)

Country Link
US (2) US20160166487A1 (es)
EP (1) EP3027184A1 (es)
JP (1) JP2016525569A (es)
KR (1) KR20160034920A (es)
CN (1) CN105555269A (es)
AU (1) AU2014297993A1 (es)
BR (1) BR112016001696A2 (es)
CA (1) CA2919979A1 (es)
CR (1) CR20160055A (es)
EA (1) EA201690302A1 (es)
HK (1) HK1225317A1 (es)
IL (1) IL243681A0 (es)
MX (1) MX2016001465A (es)
PE (1) PE20160198A1 (es)
PH (1) PH12016500096A1 (es)
SG (1) SG11201600045UA (es)
WO (1) WO2015015446A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015193631A1 (en) 2014-06-18 2015-12-23 Cipla Limited Pharmaceutical composition comprising a beta-2-agonist and anticholinergic agent
PL3325487T3 (pl) * 2015-07-21 2021-12-13 Bodor Laboratories, Inc. Preparat miękkich analogów przeciwcholinergicznych
TWI767507B (zh) 2016-07-21 2022-06-11 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑
EP3694491A1 (en) 2017-10-10 2020-08-19 Capsugel Belgium NV Gelling multiparticulates
US20220401412A1 (en) * 2019-11-05 2022-12-22 Journey Medical Corporation Methods for palmar or plantar administration of pharmaceutical compositions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824676A (en) * 1984-10-11 1989-04-25 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
US4885282A (en) 1987-07-02 1989-12-05 Thornfeldt Carl R Treatment of hyperhidrosis, ichthyosis and wrinkling
US5512555A (en) 1994-07-21 1996-04-30 Merck & Co., Inc. Method of treating sweat-related conditions using finasteride, epristeride and a cholestan-3-one
US6433003B1 (en) 1999-04-23 2002-08-13 Arthur M. Bobrove Method for treating hyperhidrosis in mammals
US8980290B2 (en) * 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
WO2004084905A2 (en) 2003-03-24 2004-10-07 University Of Florida Use of 5-ht2c receptor activity affecting compounds for treating idiopathic hyperhidrosis and associated conditions
PT2985039T (pt) 2004-03-03 2018-11-09 Revance Therapeutics Inc Aplicação tópica e administração transdérmica de toxinas botulínicas
MY144753A (en) * 2004-04-27 2011-10-31 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
US8618160B2 (en) * 2007-10-18 2013-12-31 Rose U Topical glycopyrrolate formulations
GB201113662D0 (en) * 2011-08-08 2011-09-21 Prosonix Ltd Pharmaceutical compositions
HK1212348A1 (en) * 2012-12-19 2016-06-10 Novartis Ag Autotaxin inhibitors

Also Published As

Publication number Publication date
WO2015015446A1 (en) 2015-02-05
CA2919979A1 (en) 2015-02-05
MX2016001465A (es) 2016-06-02
IL243681A0 (en) 2016-04-21
SG11201600045UA (en) 2016-02-26
EA201690302A1 (ru) 2016-06-30
KR20160034920A (ko) 2016-03-30
PE20160198A1 (es) 2016-04-21
HK1225317A1 (zh) 2017-09-08
AU2014297993A1 (en) 2016-02-04
JP2016525569A (ja) 2016-08-25
EP3027184A1 (en) 2016-06-08
US20160166487A1 (en) 2016-06-16
PH12016500096A1 (en) 2016-04-18
US20150037269A1 (en) 2015-02-05
BR112016001696A2 (pt) 2017-08-01
CN105555269A (zh) 2016-05-04

Similar Documents

Publication Publication Date Title
MX391624B (es) Métodos de uso de indazol-3-carboxamidas y su uso como inhibidores de la ruta de señalización de wnt/b-catenina.
UY35590A (es) Nuevos compuestos para el tratamiento del cáncer
MX2021001439A (es) Composiciones y metodos para el tratamiento de la disfuncion de la glandula de meibomio.
SV2015005066A (es) Compuestos de biaril-amida como inhibidores de cinasa
CL2017000469A1 (es) Derivados de tetrahidronaftaleno que inhiben la proteina mcl-1
MX383164B (es) Composicion que contiene arn para tratamiento de enfermedades tumorales.
CO6690805A2 (es) 6-amino-nicotinamidas sustituidas como modulares de kcnq2/3
MX2016014308A (es) Compuestos y composiciones como agonistas del receptor tipo toll 7.
DOP2013000192A (es) Compuestos y composiciones como inhibidores de la trk
BR112015028501A2 (pt) derivados de bipirazol como inibidores de jak
DOP2015000170A (es) Compuestos químicos
EA201691032A1 (ru) Производные изохромена в качестве ингибиторов фосфоинозитид-3-киназ
CR20160055A (es) Composiciones tópicas para el tratamiento de sudoración excesiva y métodos para utilizar las mismas
EA201600434A1 (ru) Применение производных бензимидазолпролина
BR112018008931A2 (pt) ?compostos para tratamento de distúrbios hipoproliferativos?
ECSP13012453A (es) 2-oxi-quinolina-3-carboxamidas sustituidas como moduladores KCNQ2/3
MX2018004220A (es) Tetrahidropiranilsulfonas sustituidas con pirazolilo.
BR112015023013A2 (pt) inibidores de quinase cdk9
EA201500736A1 (ru) Пиразолилкарбоксамиды i в качестве ингибиторов crac каналов
CL2015002191A1 (es) Composición antifúngica tópica para el tratamiento de onicomicosis.
MX2015013151A (es) Métodos de tratamiento de disquinesia y trastornos relacionados.
ECSP13012460A (es) 2-oxo- y 2-tioxo-dihidroquinolina-3-carboxamidas sustituidos como moduladores KCNQ2/3
MX2018004217A (es) Tetrahidropiranilsulfonas sustituidas con pirazolilo.
CL2015003460A1 (es) Composiciones oftálmicas acuosas tópicas que contienen un derivado de 1h-indol-1-carboxamida y uso de estas para el tratamiento de una enfermedad oftálmica
CL2015001502A1 (es) Composición farmacéutica que comprende desloratadina y prendnisolona y uso de la misma.